Company Filing History:
Years Active: 2021
Title: Jean-Simon Suppo: Innovator in Cancer Treatment
Introduction
Jean-Simon Suppo is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective therapies for various types of cancer, particularly renal cancer.
Latest Patents
Jean-Simon Suppo holds a patent for "Englerin derivatives for treatment of cancer." This patent discloses a compound of formula (I), where specific variables are defined. The patent also includes a pharmaceutical composition containing the compound and outlines a method for using it to treat cancer, including renal cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Suppo has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Fundació Institut Català d'Investigació Química. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Jean-Simon Suppo has collaborated with esteemed colleagues, including John A. Beutler and Antonio Echavarren. These partnerships have enriched his research and expanded the impact of his work in the field of cancer treatment.
Conclusion
Jean-Simon Suppo's innovative contributions to cancer treatment through his patented compounds highlight his dedication to improving healthcare. His work continues to inspire advancements in the pharmaceutical industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.